510(k) K081685
K081685 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "LIAISON HSV-1 TYPE SPECIFIC IGG ASSAY, CONTROL HSV-1 IGG". The FDA issued a decision of Substantially Equivalent on November 18, 2008. The device falls under product code MXJ (Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1), a Class II device regulated under 21 CFR 866.3305. DiaSorin, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 18, 2008
- Date Received
- June 17, 2008
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1
- Device Class
- Class II
- Regulation Number
- 866.3305
- Review Panel
- MI
- Submission Type